Phase 1 first-in-human study of ABBV-151 as monotherapy or in combination with budigalimab in patients with locally advanced or metastatic solid tumors Meeting Abstract


Authors: Powderly, J.; Shimizu, T.; LoRusso, P.; Razak, A.; Miller, K.; Balar, A.; Bruix, J.; Michel, L.; Blaney, M.; Guan, X.; Lacy, S.; Lally, S.; Lambert, S.; Leibman, R.; Vosganian, G.; Golan, T.; Tolcher, A.
Abstract Title: Phase 1 first-in-human study of ABBV-151 as monotherapy or in combination with budigalimab in patients with locally advanced or metastatic solid tumors
Meeting Title: 112th Annual Meeting of the American Association for Cancer Research (AACR)
Journal Title: Cancer Research
Volume: 81
Issue: 13 Suppl.
Meeting Dates: 2021 Apr 10-15/May 17-21
Meeting Location: Philadelphia, PA
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2021-07-01
Language: English
ACCESSION: WOS:000680263501290
PROVIDER: wos
DOI: 10.1158/1538-7445.AM2021-CT207
Notes: Meeting Abstract: CT207 -- Due to Covid 19 pandemic, the conference was held virtually -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Loren Michel
    63 Michel